Press "Enter" to skip to content

COVID: Maharashtra executive says Molnupiravir should be used with warning

By means of PTI

PUNE: The Maharashtra executive on Monday issued a letter to the district, civic administrations and well being departments within the state asking them to make use of oral anti-viral drug ‘Molnupiravir’ for remedy of symptomatic, grownup COVID-19 sufferers with “ample warning and in sure stipulations”.

Dr Pradeep Vyas, further leader secretary (well being), within the letter, asked district and civic government to make use of Molnupiravir with “ample warning and in sure stipulations and in complete instructed dose”.

He mentioned this drug has won emergency use authorization (from the Drug Controller Normal of India) and in response to the opinion of a few mavens it has additionally been integrated in remedy protocol circulated on January 6, 2022, within the state topic to sure stipulations.

“Due to this fact, sure state governments like Odisha have withdrawn this drug from the marketplace. ICMR has additionally now not advisable its use within the remedy of SARS-CoV-2 an infection (which reasons COVID-19). Molnupiravir has now not been integrated within the Usual Remedy Protocol launched via the Executive of India on January 17, 2022,” Dr Vyas mentioned within the letter.

Molnupiravir has been proven to scale back hospitalization in a medical trial and thus has won emergency use authorization, now not an FDA approval, the letter mentioned.

“Until additional readability is won, you might be asked to thrill use Molnupiravir with ample warning and in sure stipulations and that still in complete instructed dose,” the senior bureaucrat mentioned.

The letter-cum advisory mentioned the drug could also be “prescribed for the remedy of COVID-19 in sufferers who’ve delicate sickness now not requiring oxygen, a number of chance elements that can motive hospitalization and coming near near critical illness, in whom there are not any different choices to be had, the place there are not any contra-indications to the usage of Molnupiravir’ and within the first 5 days of the sickness”.

On the other hand, sufferers below the age of 18 and pregnant ladies will have to now not be given this drug, it maintained.

But even so district and civic heads and well being departments, the letter has been marked to district civil surgeons and well being officials.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Mission News Theme by Compete Themes.
%d bloggers like this: